Status Rapid Flu A & B Test (25 Tests/Kit)

$265.00

CLIA-Waived for Swabs
FDA-Cleared
Professional Use
25 Tests/Kit

25 tests per kit • $10.60 per test

The LifeSign STATUS Flu A & B Test is a rapid qualitative immunoassay that detects and differentiates influenza A and influenza B nucleoprotein antigens from nasal swab, nasopharyngeal swab and nasopharyngeal aspirate/wash specimens collected from patients with signs and symptoms of respiratory infection. This is an Rx-only professional test.

  • CLIA-waived when used with nasal or nasopharyngeal swab specimens
  • Read results at 10-15 minutes; confirm negative results at 15 minutes
  • Innovative flip-format test device with premeasured extraction-reagent capsules
  • Includes 25 test devices, 25 sterile swabs and positive and negative control swabs
  • Detects and differentiates influenza A and B antigens in one test
Quantity Discounts
1-5 6-10 11+
$265.00 $243.80 $230.55

LifeSign STATUS Flu A & B Test Overview

The LifeSign STATUS Flu A & B Test is an in-vitro rapid qualitative immunoassay for the direct detection and differential identification of influenza type A and type B nucleoprotein antigens. It is intended to aid healthcare professionals in the rapid differential diagnosis of influenza A and B viral infections in patients with signs and symptoms of respiratory infection.

The test accepts nasal swab, nasopharyngeal swab and nasopharyngeal aspirate/wash specimens. Its CLIA classification depends on the specimen: testing with nasal and nasopharyngeal swabs is waived, while testing with nasopharyngeal wash/aspirate specimens is moderate complexity.

CLIA-Waived for Swabs
FDA-Cleared
Professional Use
25 Tests per Kit

Features and Benefits

✓
Detects and differentiates influenza A and influenza B nucleoprotein antigens
✓
Provides results in 10-15 minutes, with negative results confirmed at 15 minutes
✓
CLIA-waived for nasal and nasopharyngeal swab specimens
✓
Innovative flip-format device with an easy-to-read result window
✓
Premeasured extraction-reagent capsules simplify swab-sample preparation
✓
Flocked sterile swabs and external positive and negative control swabs are included

Product Details

Reference
36025
SKU
DTK-357000
Package
25 Tests per Kit
Use
Rx Only / Professional In-Vitro Diagnostic Use

Professional-use test: The package insert labels this product for prescription use only. It is not an over-the-counter home test. CLIA-waived status applies only when the test is used with nasal or nasopharyngeal swab specimens; nasopharyngeal wash/aspirate testing is classified as moderate complexity.

Technical Specifications

Specification Details
Test method Rapid immunoassay for qualitative antigen detection and differentiation
Analytes Influenza A and influenza B nucleoprotein antigens
Specimens Nasal swab, nasopharyngeal swab and nasopharyngeal aspirate/wash
Result time Read at 10-15 minutes; confirm negative results at 15 minutes
CLIA complexity Waived for nasal and nasopharyngeal swabs; moderate complexity for nasopharyngeal wash/aspirate
Regulatory status FDA-cleared; Rx only
Storage 35-86°F (2-30°C) in the original sealed pouch, away from direct sunlight
Package size 25 tests per kit

Kit Contents

✓
25 individually pouched STATUS Flu A & B test devices
✓
25 extraction-reagent capsules for swab samples
✓
25 sterile swabs for specimen collection
✓
1 positive control swab containing noninfective recombinant influenza A and B nucleoprotein antigens
✓
1 negative control swab
✓
Package insert and procedure card

i

A timer and disposable gloves are required but are not included. Testing nasopharyngeal wash/aspirate specimens also requires separately available materials identified in the package insert.

Swab Test Procedure Summary

1
Add reagent: Tear the tab from one extraction-reagent capsule and dispense all solution into the device’s Extraction Well.
2
Insert and mix the swab: Place the collected specimen swab in the Extraction Well and rotate it three times.
3
Extract the specimen: Incubate the swab in the Extraction Well for 1 minute, rotate it three more times, then remove and discard it.
4
Activate the test: Raise the device upright, let it stand for 1-2 seconds, gently tap it to start liquid flow and lay it back on a level surface.
5
Read the result: Read the test at 10-15 minutes and confirm negative results at 15 minutes.

i

This summary covers only the direct swab procedure and does not replace the package insert. Follow the current instructions supplied with the kit for specimen collection, wash/aspirate testing, quality control, precautions, timing, interpretation and disposal.

Understanding the Results

A
Influenza A positive: A Control line and an Influenza A Test line appear. Any visible Test line should be interpreted as positive, even when faint.
B
Influenza B positive: A Control line and an Influenza B Test line appear. Both Test lines may appear when influenza A and B antigens are detected.
–
Negative: Only the Control line appears. Negative results are presumptive and do not rule out influenza infection.
!
Invalid: If the Control line does not appear within the designated incubation time, the result is invalid and the test must be repeated.

Negative results should not be used as the sole basis for treatment or other patient-management decisions. The package insert recommends confirming negative results by viral culture or an FDA-cleared influenza A and B molecular assay.

Clinical Performance at CLIA-Waived Sites

The manufacturer evaluated nasal and nasopharyngeal swab specimens at seven CLIA-waived sites and compared STATUS Flu A & B results with an FDA-cleared nucleic acid amplification test. The package insert reports the following combined performance:

Analyte Positive Percent Agreement Negative Percent Agreement
Influenza A 89.2% (124/139; 95% CI: 83.0-93.4%) 99.4% (314/316; 95% CI: 97.7-99.8%)
Influenza B 86.4% (133/154; 95% CI: 80.1-90.9%) 99.0% (298/301; 95% CI: 97.1-99.7%)
i

These values describe the manufacturer’s study population and comparator method; they do not guarantee the accuracy of every individual result. Specimen quality, circulating strains, disease prevalence and proper adherence to the package insert may affect performance.

Storage and Handling

✓
Store at 35-86°F (2-30°C) in the original sealed pouch and away from direct sunlight
✓
Keep the test device sealed until immediately before use
✓
Use kit components only through the expiration date printed on the pouch or box
✓
Bring reagents, specimens and devices to 64-86°F (18-30°C) before testing

Instructions and Product Documents

Frequently Asked Questions

What does the STATUS Flu A & B test detect?

It qualitatively detects and differentiates influenza A and influenza B nucleoprotein antigens as an aid in diagnosing influenza infection in symptomatic patients.

Is the STATUS Flu A & B test CLIA-waived?

It is CLIA-waived when used with nasal or nasopharyngeal swab specimens. Testing nasopharyngeal wash/aspirate specimens is classified as moderate complexity.

Is this an over-the-counter home test?

No. The package insert labels the test for prescription use only and professional in-vitro diagnostic use.

How quickly are results available?

Read results at 10-15 minutes. Negative results must be confirmed at 15 minutes.

Which specimen types can be used?

The test accepts nasal swab, nasopharyngeal swab and nasopharyngeal aspirate/wash specimens. Follow the specimen-specific procedure and CLIA classification in the package insert.

Are quality-control materials included?

Yes. The 25-test kit contains one positive control swab and one negative control swab.

Does a negative result rule out influenza?

No. Negative results are presumptive and do not preclude influenza infection. The package insert recommends confirmation with viral culture or an FDA-cleared influenza A and B molecular assay.

How should the kit be stored?

Store the kit at 35-86°F (2-30°C) in its original sealed packaging, away from direct sunlight. Use the components only through the expiration date printed on the pouch or box.

Need Current Influenza Testing Guidance?

Review CDC guidance on rapid influenza diagnostic tests, result interpretation and the limitations of negative rapid-test results.

Review CDC Rapid Influenza Testing Guidance

Additional information

Weight 6 lbs
Dimensions 10 × 10 × 5 in
Quantity

1 to 5, 6 to 10, 11+

DrugTestKitUSA Payments built in partnership with Stripe

Security at Stripe: Learn how Stripe handles security.

A PCI-certified auditor has audited Stripe. We’re a certified PCI Service Provider Level 1. This is the most stringent level of certification available in the payments industry. To accomplish this, we use the best-in-class security tools and practices to maintain a high level of security at Stripe.

HTTPS and HSTS for secure connections

Stripe forces HTTPS for all services using TLS (SSL), including our public website and the Dashboard to ensure secure connections:

  • Stripe.js is served only over TLS.
  • Stripe’s official libraries connect to Stripe’s servers over TLS and verify TLS certificates on each connection.

We regularly audit the details of our implementation, including the certificates we serve, the certificate authorities we use, and the ciphers we support. We use HSTS to ensure that browsers interact with Stripe only over HTTPS. Stripe is also on the HSTS preloaded lists for both Google Chrome and Mozilla Firefox.

Sensitive data and communication encryption

All card numbers are encrypted at rest with AES-256. Decryption keys are stored on separate machines. None of Stripe’s internal servers and daemons can obtain plain text card numbers but can request that cards are sent to a service provider on a static allowlist. Stripe’s infrastructure for storing, decrypting, and transmitting card numbers runs in a separate hosting environment, and doesn’t share any credentials with Stripe’s primary services including our API and website.

DrugTestKitUSA Accepts PayPal

Why use PayPal?

Your information is secured.

When you pay with PayPal, your financial information is never shared with the seller, and you can pay using only your email address and password.

Security around the clock.
PayPal monitors every transaction 24/7 to help prevent against fraud, email phishing and identity theft. Every transaction is heavily guarded behind their next-level encryption.

If something seems suspicious, their dedicated team of security specialists is immediately on it to help protect you from fraudulent transactions. And remember, PayPal will never ask for any sensitive information from you in an email.

You can be sure that your transaction is protected and secure when you use PayPal at the DrugTestKitUSA checkout.